insomnia
Albuterol
Instructed in new medication Albuterol to prevent or treat bronchospasm in patients with reversible obstructive airway disease. In addition, warned of possible S/E such as tremor, nervousness, dizziness, insomnia, headache, hyperactivity, weakness, CNS stimulation, malaise, tachycardia, palpitations, hypertension, dry and irritated nose and throat (with inhaled form), nasal congestion, epistaxis, hoarseness, heartburn, nausea, vomiting, anorexia, bad taste in mouth, increased appetite, hypokalemia, muscle cramps, bronchospasm, cough, wheezing, dyspnea, bronchitis, increased sputum or hypersensitivity reactions. Warned patient about possibility of paradoxical bronchospasm. If this occurs, discontinue drug immediately. If more than one inhalation is ordered, instructed to wait at least 2 minutes before repeating procedure. Use of an aero chamber may improve drug delivery to the lungs. If steroid inhaler used, advised to use the bronchodilator first and then advised to wait about 5 minutes before using the steroid. This allows the bronchodilator to open the air passages for maximum effectiveness. Advised to remove canister and wash inhaler with warm, soapy water at least once a week.
SN instructed patient / caregiver on albuterol. SN explained that albuterol is a bronchodilator indicated in COPD for opening of the airways and decrease shortness of breath. SN explained that side effects include: nervousness, restlessness, tremor, chest pain, palpitations, headache, insomnia. SN instructed to notify physician immediately if shortness of breath is not relieved or is accompanied by diaphoresis, dizziness, palpitations, or chest pain.